Allergy News and Research

RSS

The term allergy encompasses a wide range of conditions; it is not a disease in itself. In 1906 Clemens von Pirquet was the first to describe allergies as a changed or altered reaction of the immune system in response to exposure to foreign proteins. These days the term allergy – medically termed hypersensitivity, signifies an exaggerated reaction to foreign substances.

Sebum RNA could provide reliable biomarkers for detecting early-onset atopic dermatitis

Eczema is an inflammatory skin condition that often affects infants as young as one to two months. Among the various types of eczema seen in infants, early-onset atopic dermatitis (AD), characterized by psychological stress and sleep disorders, is particularly concerning.

8 Jun 2023

Nuts for the brain: Study shows nut consumption boosts memory and brain health in seniors

Long-term consumption of mixed nuts in older adults improves brain vascular function and may enhance cognitive performance. The study highlights the potential benefits of nut consumption for brain health in aging populations.

6 Jun 2023

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

Researchers at the University of Louisville have received $5.8 million in two grants from the National Institutes of Health to expand their work to better understand and prevent immune system dysregulation responsible for acute respiratory distress, the condition responsible for serious illness and death in some COVID-19 patients.

2 Jun 2023

Scientists investigate how immune system's T cells could fight many coronaviruses at once

Scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system's T cells react to a wide variety of coronaviruses, ranging from SARS to common cold coronaviruses.

1 Jun 2023

NIH scientists identify genomic variants that cause rare inflammatory skin disorder

Researchers at the National Institutes of Health and their colleagues have identified genomic variants that cause a rare and severe inflammatory skin disorder, known as disabling pansclerotic morphea, and have found a potential treatment.

31 May 2023

Genetic change supercharged spread and severity of epizootic H5N1 avian influenza virus

St. Jude Children's Research Hospital scientists discovered how the current epizootic H5N1 avian influenza virus (bird flu) gained new genes and greater virulence as it spread west.

30 May 2023

New method may help identify the essential ingredients for making an effective HIV vaccine

Since it was identified in 1984 as the cause of Acquired Immune Deficiency Syndrome (AIDS), the human immunodeficiency virus (HIV) has infected more than 80 million people and been responsible for some 40 million deaths worldwide, according to the World Health Organization (WHO).

30 May 2023

Study shows how IgA acts as a "tuner" to keep the immune system in check

IgA deficiency is the most common primary immune deficiency worldwide, but its presentation has puzzled physcians and researchers.

26 May 2023

MHRA authorizes new COVID-19 vaccine from SK Chemicals

SKYCovion, the COVID-19 vaccine developed by SK Chemicals, has today been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA).

26 May 2023

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Researchers from Fred Hutchinson Cancer Center in Seattle, Scripps Research in La Jolla, California, IAVI and other collaborating institutions have characterized robust T-cell responses in volunteers participating in the IAVI G001 Phase 1 clinical trial to test the safety and immune response of a self-assembling nanoparticle HIV vaccine.

25 May 2023

$Using 3D-electron diffraction to determine the structure of Levocetirizine dihydrochloride$

Using 3D-electron diffraction to determine the structure of Levocetirizine dihydrochloride

For pharmaceuticals, knowing the chemical composition is not enough-;molecular geometry and crystal structure also play an important role in a drug's activity.

23 May 2023

Study shows the potential of TAp63 as a new therapeutic target for rheumatoid arthritis

Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint deterioration. The clinical outcomes of patients with active RA can be improved using anti-rheumatic medications, such as methotrexate (MTX).

22 May 2023

Mouse study offers clues to developing an effective vaccine for Klebsiella bacteria

A mouse study at Washington University School of Medicine in St. Louis points to data that could be key to developing an effective vaccine for the bacterium Klebsiella pneumoniae.

18 May 2023

Phase 1 trial of experimental universal influenza vaccine begins enrolling volunteers

A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolina.

15 May 2023

Allergy News and Research

Further Reading

Sebum RNA could provide reliable biomarkers for detecting early-onset atopic dermatitis

Nuts for the brain: Study shows nut consumption boosts memory and brain health in seniors

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

Scientists investigate how immune system's T cells could fight many coronaviruses at once

NIH scientists identify genomic variants that cause rare inflammatory skin disorder

Genetic change supercharged spread and severity of epizootic H5N1 avian influenza virus

New method may help identify the essential ingredients for making an effective HIV vaccine

Study shows how IgA acts as a "tuner" to keep the immune system in check

MHRA authorizes new COVID-19 vaccine from SK Chemicals

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Using 3D-electron diffraction to determine the structure of Levocetirizine dihydrochloride

Study shows the potential of TAp63 as a new therapeutic target for rheumatoid arthritis

Mouse study offers clues to developing an effective vaccine for Klebsiella bacteria

Phase 1 trial of experimental universal influenza vaccine begins enrolling volunteers

First-in-human clinical trial tests experimental oral drug for removing radioactive contaminants

Robo-diets: can ChatGPT formulate safe dietary advice?

UCF researcher develops a new, more precise treatment for acute respiratory viral infections

Understanding Lupus: an interview with the Garvan Institute

AI tools can help simplify a test that works for hepatitis C and SARS-CoV-2

Cancer-fighting immune cells can fuel their ability to attack tumors

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News